Rinri Therapeutics

Rinri Therapeutics is a private, clinical-stage biotech focused on a groundbreaking therapeutic area: regenerative cell therapy for hearing loss. The company leverages foundational research in auditory stem cells from Professor Marcelo Rivolta at the University of Sheffield. With a portfolio of first-in-class programs, Rinri aims to address the significant unmet medical need in sensorineural hearing loss, a condition with no current curative treatments. The company is positioned as a leader in translating auditory regeneration science into clinical reality.

Regenerative cell therapy platform based on auditory stem cell research for differentiating progenitor cells into sensory hair cells and auditory neurons.

The field of hearing restoration is emerging with a handful of companies exploring gene therapies (e.g., Decibel Therapeutics, Akouos) and other regenerative approaches. Rinri is a notable player focused specifically on cell therapy, placing it in a unique but unproven competitive niche.